511509 Stock Overview
Provides drug development and discovery services to pharmaceutical and biotech companies worldwide. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Vivo Bio Tech Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹39.98 |
| 52 Week High | ₹56.00 |
| 52 Week Low | ₹30.75 |
| Beta | 0.79 |
| 11 Month Change | 10.56% |
| 3 Month Change | 4.03% |
| 1 Year Change | 23.09% |
| 33 Year Change | -37.58% |
| 5 Year Change | 28.97% |
| Change since IPO | -43.85% |
Recent News & Updates
Recent updates
Shareholder Returns
| 511509 | IN Life Sciences | IN Market | |
|---|---|---|---|
| 7D | 18.6% | 1.2% | 0.3% |
| 1Y | 23.1% | 48.2% | 27.3% |
Return vs Industry: 511509 underperformed the Indian Life Sciences industry which returned 47.9% over the past year.
Return vs Market: 511509 underperformed the Indian Market which returned 27.2% over the past year.
Price Volatility
| 511509 volatility | |
|---|---|
| 511509 Average Weekly Movement | 6.2% |
| Life Sciences Industry Average Movement | 6.5% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in IN Market | 9.2% |
| 10% least volatile stocks in IN Market | 4.0% |
Stable Share Price: 511509 has not had significant price volatility in the past 3 months compared to the Indian market.
Volatility Over Time: 511509's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1987 | 161 | Alangudi Sankaranarayanan | www.vivobio.com |
Vivo Bio Tech Limited provides drug development and discovery services to pharmaceutical and biotech companies worldwide. The company offers services in the areas of in vivo and in vitro toxicity studies, pharmacological investigations, pharmacokinetic and toxic kinetic studies, genotoxicity screening, and analytical services. It also supplies SPF lab animals; breeds and distributes rodent models; and offers custom rodent models, and stem cell products, as well as lab animal diets.
Vivo Bio Tech Limited Fundamentals Summary
| 511509 fundamental statistics | |
|---|---|
| Market cap | ₹595.84m |
| Earnings (TTM) | ₹74.57m |
| Revenue (TTM) | ₹514.20m |
8.0x
P/E Ratio1.2x
P/S RatioIs 511509 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 511509 income statement (TTM) | |
|---|---|
| Revenue | ₹514.20m |
| Cost of Revenue | ₹54.50m |
| Gross Profit | ₹459.70m |
| Other Expenses | ₹385.13m |
| Earnings | ₹74.57m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 5.00 |
| Gross Margin | 89.40% |
| Net Profit Margin | 14.50% |
| Debt/Equity Ratio | 96.8% |
How did 511509 perform over the long term?
See historical performance and comparison